StockData
Alvotech logo

Alvotech (ALVO) stock

ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$4.37−0.04 (-0.79%)

Close on Nov 17, 2026Market cap $1.36BP/E 43.7Yield –

Alvotech total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Alvotech's total debt was $1.31B at Jun 30, 2026. For fiscal 2025 it was $1.30B, up 21.6% from the year before. The highest annual figure on record is $1.30B in fiscal 2025.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.30B+21.6%
FY2024Dec 31, 2024$1.07B+11.3%
FY2023Dec 31, 2023$960.16M+22.4%
FY2022Dec 31, 2022$784.49M+95.7%
FY2021Dec 31, 2021$400.91M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.31B+23.7%
Q4 FY2025Dec 31, 2025$1.30B+35.3%
Q2 FY2025Jun 30, 2025$1.12B+42.2%
Q4 FY2024Dec 31, 2024$1.07B+36.2%
Q2 FY2024Jun 30, 2024$1.06B+163.4%
Q4 FY2023Dec 31, 2023$960.16M–
Q2 FY2023Jun 30, 2023$786.18M–
Q4 FY2022Dec 31, 2022$784.49M–
Q4 FY2021Dec 31, 2021$400.91M–

More Alvotech figures

See a number that looks wrong?